Boston Scientific lands in Boston after Penumbra acquisition vote

Boston Scientific's Challenger 650, tail number N650BS, touched down at Hanscom Field in Bedford, Massachusetts, on May 7, 2026, after a brief 55-minute hop from Teterboro Airport in New Jersey. The flight, departing around 8:25 p.m. Eastern time, capped a day of shuttling between the Boston area and the New York metro region, reaching a modest cruising altitude of 15,200 feet.

The timing aligns with a pivotal moment for the medical device giant: just one day earlier, on May 6, Boston Scientific shareholders convened a special meeting to approve the company's $14.5 billion acquisition of Penumbra Inc., a deal first announced in January to expand its cardiovascular offerings amid rising vascular disease prevalence, per a Reuters report from that month. With the vote in the books—backed unanimously by the board, according to SEC filings—the return to Marlborough headquarters likely signals the start of integration planning for the Alameda-based target.

This homecoming follows a pattern of cross-country executive travel for Boston Scientific, whose recurring routes include hubs like Washington Dulles, London Heathrow, Chicago O'Hare, and San Francisco. Just days prior, on May 5, the jet ferried from near Seattle to Boston, possibly tying into broader deal-making or supplier meetings, before the New York day trips that bookended the acquisition milestone.